Gene Editing as a Potential Therapeutic Solution for Fuchs Endothelial Corneal Dystrophy: The Future Is Clearer

JAMA Ophthalmol. 2018 Sep 1;136(9):969-970. doi: 10.1001/jamaophthalmol.2018.2324.
No abstract available

MeSH terms

  • Fuchs' Endothelial Dystrophy / genetics
  • Fuchs' Endothelial Dystrophy / therapy*
  • Gene Editing / methods*
  • Humans
  • Transcription Factor 4 / genetics

Substances

  • TCF4 protein, human
  • Transcription Factor 4